32 research outputs found
PUK5 EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS IN ANEMIC PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
Get PDFPCN86 DRUG UTILIZATION AND COST CONSIDERATIONS OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Get PDF
PUK5 EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS IN ANEMIC PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
No full textCS1 EPOETIN ALFA AND DARBEPOETIN ALFA DOSING TRENDS AND DRUG COSTS IN ELDERLY PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS
No full textPCV154 USING DIFFERENT MEASURES TO DETERMINE TIME IN THERAPEUTIC INR RANGE AMONG WARFARIN-TREATED PATIENTS FOLLOWING TOTAL HIP OR KNEE REPLACEMENT
No full textStudy of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents.
No full textPCN21 DRUG UTILIZATION, COST CONSIDERATIONS AND TRANSFUSION PATTERNS FOR ERYTHROPOIETIC STIMULATING AGENTS IN A MANAGED CARE CANCER POPULATION
Get PDFPDB70 IMPACT OF ANEMIA ON HOSPITALIZATION COSTS IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE
No full textPHM2 STUDY OF ANEMIA IN LONG-TERM CARE (SALT): RELATIONSHIP BETWEEN ANEMIA AND FALLS IN THE NURSING HOME SETTING
No full text
